» Articles » PMID: 24397600

Low-density Lipoprotein-mediated Delivery of Docosahexaenoic Acid Selectively Kills Murine Liver Cancer Cells

Overview
Specialty Biotechnology
Date 2014 Jan 9
PMID 24397600
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: The natural omega-3 polyunsaturated fatty acid, docosahexaenoic acid (DHA), has recently been credited for possessing anticancer properties. Herein, we investigate the cytotoxic actions of DHA-loaded low-density lipoprotein (LDL) nanoparticles in normal and liver cancer cells.

Materials & Methods: LDL-DHA nanoparticles were prepared and subjected to extensive biophysical characterization. The therapeutic utility of LDL-DHA nanoparticles was evaluated in normal and malignant murine hepatocyte cell lines, TIB-73 and TIB-75, respectively.

Results & Discussion: The engineered LDL-DHA nanoparticles possessed enhanced physical and oxidative stabilities over native LDL and free DHA. Dose-response studies showed that therapeutic doses of LDL-DHA nanoparticles that completely killed TIB-75 were innocuous to TIB-73. The selective induction of lipid peroxidation and reactive oxygen species in the cancer cells was shown to play a central role in LDL-DHA nanoparticle-mediated cytotoxicity.

Conclusion: In summary, these findings indicate that LDL-DHA nanoparticles show great promise as a selective anticancer agent against hepatocellular carcinoma.

Citing Articles

APT imaging of hepatocellular carcinoma signals an effective therapeutic response in advance of tumor shrinkage.

Wang X, Ishimatsu K, Li J, Wen X, Ou W, Anwar A Hepat Oncol. 2025; 11(1):2389031.

PMID: 39881558 PMC: 11407511. DOI: 10.1080/20450923.2024.2389031.


Cell Membrane Fatty Acids and PIPs Modulate the Etiology of Pancreatic Cancer by Regulating AKT.

Torres C, Mancinelli G, Chen J, Cordoba-Chacon J, Pins D, Saeed S Nutrients. 2025; 17(1).

PMID: 39796583 PMC: 11722924. DOI: 10.3390/nu17010150.


Nano-Formulations of Natural Antioxidants for the Treatment of Liver Cancer.

Cristani M, Citarella A, Carnamucio F, Micale N Biomolecules. 2024; 14(8).

PMID: 39199418 PMC: 11352298. DOI: 10.3390/biom14081031.


Docosahexaenoic acid-loaded nanoparticles: A state-of-the-art of preparation methods, characterization, functionality, and therapeutic applications.

Ali A, Hachem M, Ahmmed M Heliyon. 2024; 10(9):e30946.

PMID: 38774069 PMC: 11107210. DOI: 10.1016/j.heliyon.2024.e30946.


Low-density lipoprotein: a versatile nanoscale platform for targeted delivery.

Dai L, Li S, Hao Q, Zhou R, Zhou H, Lei W Nanoscale Adv. 2023; 5(4):1011-1022.

PMID: 36798503 PMC: 9926902. DOI: 10.1039/d2na00883a.


References
1.
Wang L, Walsh M, Small D . Apolipoprotein B is conformationally flexible but anchored at a triolein/water interface: a possible model for lipoprotein surfaces. Proc Natl Acad Sci U S A. 2006; 103(18):6871-6. PMC: 1458986. DOI: 10.1073/pnas.0602213103. View

2.
PANDE S, Mead J . Inhibition of enzyme activities by free fatty acids. J Biol Chem. 1968; 243(23):6180-5. View

3.
Ogunwobi O, Liu C . Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. Clin Exp Metastasis. 2011; 28(8):721-31. PMC: 3732749. DOI: 10.1007/s10585-011-9404-x. View

4.
Masquelier M, Tirzitis G, Peterson C, Palsson M, Amolins A, Plotniece M . Plasma stability and cytotoxicity of lipophilic daunorubicin derivatives incorporated into low density lipoproteins. Eur J Med Chem. 2000; 35(4):429-38. DOI: 10.1016/s0223-5234(00)00139-2. View

5.
Gal D, Ohashi M, MACDONALD P, Buchsbaum H, Simpson E . Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms. Am J Obstet Gynecol. 1981; 139(8):877-85. DOI: 10.1016/0002-9378(81)90952-2. View